{
    "title": "Professor's 15-year journey ends with $273m drug deal",
    "url": "https://www.dailymail.co.uk/wires/aap/article-12049383/Professors-15-year-journey-ends-273m-drug-deal.html",
    "date": "2023-05-05",
    "keywords": [
        "brain",
        "university",
        "system",
        "partnership",
        "behaviour",
        "kassiou",
        "oxytocin",
        "dysfunction",
        "bowen",
        "school",
        "research",
        "precision",
        "company",
        "sydney",
        "boehringer",
        "ingelheim",
        "michael",
        "target",
        "life",
        "psychology",
        "mind",
        "depression",
        "dementia",
        "schizophrenia",
        "biotechnology",
        "deal",
        "kinoxis",
        "partner",
        "technology",
        "neuropeptide",
        "chemical",
        "role",
        "regulation",
        "industryuniversity",
        "friday",
        "highlight",
        "career",
        "functioning",
        "drug",
        "discovery",
        "series",
        "receptor",
        "quality",
        "symptom",
        "withdrawal",
        "aggression",
        "difficulty",
        "forming",
        "use",
        "cofounder",
        "associate",
        "professor",
        "venture",
        "fund",
        "promise",
        "treatment",
        "dr",
        "aap",
        "player",
        "development",
        "arrangement",
        "team",
        "world",
        "program",
        "rate",
        "funding",
        "chemistry",
        "centre",
        "example",
        "translation",
        "commercialisation",
        "vicechancellor",
        "president",
        "mark",
        "scott"
    ],
    "category": [
        "wires",
        "aap"
    ]
}